News

Stockhead on MSN14h
Why $487 million US distribution deal is a ‘watershed moment’ for skyrocketing biotech Lumos
Lumos Diagnostics (ASX:LDX) has skyrocketed more than 150% after inking a landmark six-year distributor deal worth hundreds ...
Health Check: Lumos shares 150pc brighter after company-making US diagnostics deal
In one of the “largest distribution deals of its type” by an ASX-listed point-of-care diagnostics company, minnow Lumos ...